FDA Approved: EVOMELA — Supplemental Application (Acrotech Biopharma Inc)

View source ↗

Summary

FDA approves a supplemental application for EVOMELA (melphalan) from Acrotech Biopharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• EVOMELA (melphalan hydrochloride)

Snippet

SUPPL AP for EVOMELA (MELPHALAN)